SE7415305L - - Google Patents

Info

Publication number
SE7415305L
SE7415305L SE7415305A SE7415305A SE7415305L SE 7415305 L SE7415305 L SE 7415305L SE 7415305 A SE7415305 A SE 7415305A SE 7415305 A SE7415305 A SE 7415305A SE 7415305 L SE7415305 L SE 7415305L
Authority
SE
Sweden
Prior art keywords
peptide
polymer
bound
liquid phase
synthesis
Prior art date
Application number
SE7415305A
Other languages
English (en)
Inventor
E Bayer
M Mutter
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7415305L publication Critical patent/SE7415305L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
SE7415305A 1973-12-06 1974-12-06 SE7415305L (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2360794A DE2360794C2 (de) 1973-12-06 1973-12-06 Verfahren zur Herstellung von Peptiden

Publications (1)

Publication Number Publication Date
SE7415305L true SE7415305L (xx) 1975-06-09

Family

ID=5900062

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7415305A SE7415305L (xx) 1973-12-06 1974-12-06

Country Status (12)

Country Link
US (1) US3960830A (xx)
JP (1) JPS5088003A (xx)
BE (1) BE823064A (xx)
CH (1) CH605679A5 (xx)
DE (1) DE2360794C2 (xx)
DK (1) DK633374A (xx)
FR (1) FR2253736B1 (xx)
GB (1) GB1464938A (xx)
IE (1) IE40281B1 (xx)
LU (1) LU71415A1 (xx)
NL (1) NL7415602A (xx)
SE (1) SE7415305L (xx)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997516A (en) * 1974-07-04 1976-12-14 Takeda Chemical Industries, Ltd. Method for protecting guanidino group and restoring the same
DE2930542A1 (de) * 1979-07-27 1981-02-12 Hoechst Ag Neue insulinderivate und verfahren zu ihrer herstellung
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US4908404A (en) * 1988-08-22 1990-03-13 Biopolymers, Inc. Synthetic amino acid-and/or peptide-containing graft copolymers
US5565519A (en) * 1988-11-21 1996-10-15 Collagen Corporation Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
JPH0520266U (ja) * 1991-01-31 1993-03-12 松下電器産業株式会社 電気部品の接続装置
EP0536671B1 (de) * 1991-10-07 1996-03-06 Hoechst Aktiengesellschaft Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US7883693B2 (en) * 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
EP1704878B1 (en) * 1995-12-18 2013-04-10 AngioDevice International GmbH Crosslinked polymer compositions and methods for their use
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
DE69914611T2 (de) * 1998-08-28 2004-12-23 Gryphon Therapeutics, Inc., South San Francisco Verfahren zur herstellung von polyamidketten von genauer länge und deren konjugate mit proteinen
DK1656952T3 (da) * 1998-10-16 2014-01-20 Biogen Idec Inc Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US8129330B2 (en) * 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
EP2181704B1 (en) * 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20040219214A1 (en) * 2002-12-30 2004-11-04 Angiotech International Ag Tissue reactive compounds and compositions and uses thereof
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
CN101080246A (zh) 2004-04-28 2007-11-28 安希奥设备国际有限责任公司 用于形成交联生物材料的组合物和系统及关联的制备方法与用途
EP1789437A4 (en) * 2004-07-30 2008-11-05 Sinai School Medicine INHIBITORS OF NPC1L1 AND NPC1L1 AND METHODS OF USE THEREOF
CA2581093C (en) 2004-09-17 2014-11-18 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
CN101277921B (zh) * 2005-09-20 2013-05-22 Jitsubo株式会社 分离用载体、化合物的分离方法以及利用其的肽合成方法
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
CA2677948C (en) * 2007-02-12 2014-12-09 Biotempt B.V. Treatment of trauma-hemorrhage with short oligopeptides
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
PL2376101T3 (pl) 2008-12-29 2016-03-31 Trevena Inc Elektory beta-arestyny oraz ich kompozycje i sposoby stosowania
JP2017506235A (ja) * 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ベータ−アレスチンエフェクターの結晶性および非晶質形態
CN106456698B (zh) 2014-05-19 2022-05-17 特维娜有限公司 β-抑制蛋白效应物的合成
US20170290892A1 (en) * 2014-07-14 2017-10-12 Peg Biosciences, Inc. Polymeric enkephalin prodrugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (xx) * 1967-05-23 1971-08-02 Pharmacia Ab
US3502545A (en) * 1968-09-27 1970-03-24 Monsanto Co Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel

Also Published As

Publication number Publication date
BE823064A (fr) 1975-06-06
FR2253736A1 (xx) 1975-07-04
FR2253736B1 (xx) 1978-09-15
LU71415A1 (xx) 1976-11-11
JPS5088003A (xx) 1975-07-15
IE40281L (en) 1975-06-06
IE40281B1 (en) 1979-04-25
CH605679A5 (xx) 1978-10-13
US3960830A (en) 1976-06-01
NL7415602A (nl) 1975-06-10
DK633374A (xx) 1975-07-21
DE2360794C2 (de) 1984-12-06
GB1464938A (en) 1977-02-16
DE2360794A1 (de) 1975-06-26

Similar Documents

Publication Publication Date Title
SE7415305L (xx)
IL44828A0 (en) Isolation of coagulation factors from biological material
PH11995A (en) Process for the recovery of proteins
BE821121A (fr) Procede de preparation d'un produit alimentaire proteique.
ZA735376B (en) Process for the separation of aliphatically unsaturated hydrocarbons from gaseous mixtures by permeation
BE821211A (fr) Procede de preparation d'un produit alimentaire proteique.
CH537905A (fr) Procédé de préparation de synthèse de peptides
CH551151A (fr) Procede de preparation d'une fraction des proteines du soja.
BE806985A (fr) Support polymere pour la synthese dirigee de peptide et procede de preparation
YU297374A (en) Process for purifying water by means of distillation
CS185663B2 (en) Mode of continual separation of nitrates from solution
FR2306005A1 (fr) Procede pour separer des melanges de substances, de preference gazeux
IT1044732B (it) Procedimento per la produzione di materiali proteici mediante fermentazione
BE785933A (fr) Procede de preparation de peptides contenant de la cystine
BE820897A (nl) Werkwijze voor de bereiding van synthese gas
IT985014B (it) Procedimento per la separazio ne di idrocarburi alifatici insaturi in particolare etilene da miscele
CA1019324A (en) Process for producing peptides
RO70609A (ro) Procedeu pentru prepararea unor peptide cu actiune acth
BE823476A (fr) Procede de moulage de cuves funeraires rigides
ZA747991B (en) Process for the purification of peptides
ZA744679B (en) Process for the recovery of proteins
BE815403A (fr) Procede de preparation de peptides contenant de la cystine
FR2347335A1 (fr) Nouveaux peptides, resine-peptides intermediaires pour la synthese de ces peptides et procede de synthese de ces resine-peptides intermediaires
CA964385A (en) Process and apparatus for separating proteins from sea water by ozone
CA978987A (en) Method of moving acids from reaction liquid of dimethyl dioxane synthesis

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7415305-7